FFO
TXG icon

Fortitude Family Office’s 10x Genomics TXG Stock Holding History

Fortitude Family Office’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.9K Buy
859
+679
+377% +$17.8K 0.01% 386
2026
Q1 		$3.82K Sell
180
-130
-42% -$2.6K ﹤0.01% 1024
2025
Q4 		$5.06K Hold
310
– – ﹤0.01% 804
2025
Q3 		$3.62K Hold
310
– – ﹤0.01% 942
2025
Q2 		$3.59K Buy
+310
New +$2.83K ﹤0.01% 925

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fortitude Family Office's TXG Position: Q2 2026 in Review

Fortitude Family Office increased its 10x Genomics (TXG) stake by 377% in Q2 2026, buying an estimated $17.8K and bringing the position to 859 shares worth $32.9K. The position accounts for 0.01% of the portfolio, ranked #386.

Fortitude Family Office first reported a position in TXG in Q2 2025 and has held it in 5 quarters since. 393 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Fortitude Family Office held 859 shares of 10x Genomics worth $32.9K as of Q2 2026.
  • Fortitude Family Office bought 679 10x Genomics shares in Q2 2026, an estimated $17.8K.
  • 10x Genomics made up 0.01% of Fortitude Family Office's portfolio in Q2 2026, its #386 holding.
  • Fortitude Family Office first reported a position in 10x Genomics in Q2 2025 and has held it in 5 quarters since.
  • 393 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.